Duvos C, Scutt A, Mayer H
Gesellschaft für Biotechnologischs Forschung mbH, Department of Generegulation and Differentiation, Braunschweig, Germany.
In Vitro Cell Dev Biol Anim. 1997 Jun;33(6):473-8. doi: 10.1007/s11626-997-0066-6.
We have investigated single and combined effects of calciotropic hormones and growth factors on the regulation of alkaline phosphatase (ALP) activity and calcium metabolism in an optimized serum-free bone organ culture system of embryonic chick tibiae. Parathyroid hormone PTH(1-34) alone mobilized calcium from bone tissue time- and dose-dependently and inhibited ALP activity. Both the bisphosphonate (BM 21.0955) and to a lesser extent salmon calcitonin alone slightly increased calcium uptake and inhibited the stimulation of bone resorption by PTH(1-34). 1,25(OH)2D3 mobilized calcium and inhibited ALP activity in contrast to 24,25(OH)2D3 which inhibited ALP activity but had no significant effect on calcium metabolism. Interestingly the combination of PTH(1-34) with 1,25(OH)2D3 but not 24,25(OH)2D3 reduced calcium mobilization. The combination of the midregional fragment PTH(28-48), which by itself has no effect on calcium metabolism, with 1,25(OH)2D3 reduced calcium mobilization more efficiently. Several PTH-regulated mediators have been assayed in this system. Of the tested growth factors, IGF-I at high concentrations caused bone resorption with no effect on ALP activity. TGF-beta 1 (transforming growth factor beta) and BMP-2 had no significant effect on calcium metabolism; however, ALP activity was inhibited by TGF-beta 1 and induced dose dependently by BMP-2. Of the other factors known to be present in bone, platelet-derived growth factor (PDGFA/B) and epidermal growth factor (EGF) had a small effect on calcium mobilization but had no effect on ALP activity. bFGF reduced ALP activity slightly without an effect on calcium metabolism. Our results show that this in vitro system can mimic some interactions of calciotropic hormones in vivo and allows the assaying of mediators in terms of regulation of ALP activity and of calcium metabolism.
我们在优化的鸡胚胫骨无血清骨器官培养系统中,研究了钙调节激素和生长因子对碱性磷酸酶(ALP)活性及钙代谢调节的单一和联合作用。单独使用甲状旁腺激素PTH(1-34)可使骨组织中的钙呈时间和剂量依赖性动员,并抑制ALP活性。双膦酸盐(BM 21.0955)以及单独使用程度较轻的鲑鱼降钙素均能轻微增加钙摄取,并抑制PTH(1-34)对骨吸收的刺激作用。与24,25(OH)2D3相反,1,25(OH)2D3可动员钙并抑制ALP活性,而24,25(OH)2D3抑制ALP活性,但对钙代谢无显著影响。有趣的是,PTH(1-34)与1,25(OH)2D3联合使用可减少钙动员,而与24,25(OH)2D3联合则无此作用。自身对钙代谢无影响的中段区域片段PTH(28-48)与1,25(OH)2D3联合使用时,能更有效地减少钙动员。在该系统中已检测了几种PTH调节的介质。在测试的生长因子中,高浓度胰岛素样生长因子-I(IGF-I)可引起骨吸收,对ALP活性无影响。转化生长因子-β1(TGF-β1)和骨形态发生蛋白-2(BMP-2)对钙代谢无显著影响;然而,TGF-β1抑制ALP活性,BMP-2则剂量依赖性诱导ALP活性。在已知存在于骨中的其他因子中,血小板衍生生长因子(PDGFA/B)和表皮生长因子(EGF)对钙动员有轻微影响,但对ALP活性无影响。碱性成纤维细胞生长因子(bFGF)可轻微降低ALP活性,对钙代谢无影响。我们的结果表明,该体外系统可模拟体内钙调节激素的一些相互作用,并能在ALP活性和钙代谢调节方面检测介质。